KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Free Cash Flow (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Free Cash Flow data on record, last reported at $326.3 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 115.39% year-over-year to $326.3 million; the TTM value through Dec 2025 reached $1.1 billion, up 30.82%, while the annual FY2025 figure was $1.1 billion, 30.82% up from the prior year.
  • Free Cash Flow reached $326.3 million in Q4 2025 per IDXX's latest filing, up from $315.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $326.3 million in Q4 2025 and bottomed at $44.3 million in Q4 2022.
  • Average Free Cash Flow over 5 years is $183.4 million, with a median of $178.9 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: surged 657.62% in 2021, then tumbled 75.16% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at $178.2 million in 2021, then crashed by 75.16% to $44.3 million in 2022, then skyrocketed by 188.24% to $127.5 million in 2023, then grew by 18.79% to $151.5 million in 2024, then soared by 115.39% to $326.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $326.3 million in Q4 2025, $315.6 million in Q3 2025, and $207.3 million in Q2 2025.